Burning Rock Biotech (BNR) Capital Leases (2019 - 2021)
Burning Rock Biotech (BNR) posted quarterly Capital Leases of $116000.0 for Q3 2020, down 62.21% quarter-over-quarter from $307000.0 in Q2 2020.
Burning Rock Biotech (BNR) Capital Leases (2019 - 2021) Analysis & Trends
Burning Rock Biotech's Capital Leases history runs 2 years deep, the most recent figure standing at $116000.0 for Q3 2020.
- In Q3 2020, Capital Leases changed N/A year-over-year to $116000.0; the TTM figure through Sep 2020 stood at $116000.0 (changed N/A YoY), while the FY2019 annual figure was $697491.0, changed N/A from the prior year.
- Capital Leases for Q3 2020 stood at $116000.0, down from $307000.0 in the prior quarter.
- The five-year high for Capital Leases was $683297.8 in Q4 2019, with the low at $116000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Burning Rock Biotech | 84.09 Mn | 14.24 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -799,409.42 |
| Dec 31, 2020 | -738,320.90 |
| Sep 30, 2020 | 116,000.00 |
| Jun 30, 2020 | 307,000.00 |
| Dec 31, 2019 | -661,731.91 |